Table 1.
Human papillomavirus (HPV), human immunodeficiency virus (HIV), p16, and Ki-67 status in esophageal squamous cell carcinoma (ESCC), dysplasia and histopathologically normal biopsies.
Study Number | Hist. Diagn. 1 | Grading | Ki-67 Index Overall 2 | p16INK4a Staining Pattern 3 | p16INK4a Stained Tumor Cell Areas 4 | % of Ki-67 Stained Cells within p16INK4a Stained Areas | HPV qPCR 5 | HPV ISH 6 | HIV Status 7 |
---|---|---|---|---|---|---|---|---|---|
HV090610-44 | 1 | 1 | 3 | 2 | 1 | 71 | 1 | 0 | 0 |
DV280610-68 | 1 | 1 | 3 | 1 | 2 | 88 | 1 | 0 | 0 |
EC070710-73 | 2 | - | 3 | 1 | 2 | 51 | 1 | 0 | 0 |
FN280710-105 | 1 | 1 | 3 | 1 | 2 | 67 | 1 | 0 | - |
AM240510-22 | 1 | 2 | 3 | 1 | 2 | 61 | 1 | 0 | 0 |
JS070710-72 | 1 | 1 | 3 | 1 | 2 | 72 | 1 | 0 | 0 |
MRD160610-57 | 1 | 2 | - | - | - | - | 1 | - | 0 |
PD120510-1 | 1 | 2 | 3 | 0 | 0 | - | 0 | 0 | 0 |
CC050710-70 | 2 | - | 3 | 0 | 0 | - | 0 | 0 | 1 |
AM14071087 | 1 | 2 | 2 | 2 | 2 | 26 | 0 | 0 | 0 |
EK070610-40 | 1 | 2 | 3 | 0 | 0 | - | 0 | - | 0 |
SN210710-101 | 1 | 2 | 3 | 0 | 0 | - | 0 | - | - |
SN210710-96 | 1 | 2 | 3 | 0 | 0 | - | 0 | - | - |
HM070710-74 | 1 | 3 | - | - | - | - | 0 | - | 0 |
LI190710-91 | 1 | 2 | - | - | - | - | 0 | - | - |
DM090610-41 | 1 | 2 | 3 | 1 | 2 | 60 | 0 | - | 0 |
AOM160610-55 | 1 | 2 | 3 | 1 | 2 | 53 | 0 | 0 | 0 |
MG260510-29 | 1 | 2 | 3 | 1 | 2 | 55 | 0 | - | 0 |
EO160610-59 | 1 | 3 | 3 | 1 | 1 | 60 | 0 | - | 0 |
LC150610-97 | 1 | 2 | 2 | 1 | 2 | 25 | 0 | - | - |
LM180510-10 | 1 | 2 | 3 | 0 | 0 | - | 0 | - | 1 |
PL130710-81 | 1 | 2 | 2 | 1 | 2 | 46 | 0 | 0 | 0 |
RC170510-7 | 1 | 2 | 2 | 1 | 2 | 45 | 0 | - | 0 |
EM280610-69 | 2 | - | 3 | 1 | 2 | 67 | 0 | - | 0 |
LN180510-12 | 1 | 3 | 2 | 0 | 0 | - | 0 | - | - |
ESL190510-17 | 1 | 3 | 2 | 1 | 2 | 48 | 0 | - | 0 |
JC260710-102 | 1 | 2 | 3 | 0 | 0 | - | 0 | - | - |
DL160610-56 | 1 | 3 | 2 | 1 | 2 | 49 | 0 | - | 1 |
JC120510-2 | 1 | 2 | 3 | 0 | 0 | - | 0 | - | 0 |
JN140610-54 | 1 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
RM170510-8 | 1 | 2 | 2 | 1 | 2 | 47 | 0 | - | 0 |
ZV160610-58 | 1 | 2 | 3 | 1 | 1 | 62 | 0 | - | 0 |
SF270710-103 | 1 | - | 2 | 0 | 0 | - | 0 | - | - |
FM140710-86 | 1 | 3 | 3 | 1 | 2 | 54 | 0 | - | 0 |
OD120510-3 | 1 | 2 | 2 | 1 | 2 | 45 | 0 | - | 0 |
DK280610-66 | 1 | 3 | 3 | 1 | 1 | 78 | 0 | - | 0 |
MJ020610-34 | 1 | 3 | 2 | 0 | 0 | - | 0 | - | 1 |
JK140710-89 | 1 | 2 | 3 | 1 | 2 | 65 | 0 | - | 0 |
RM210710-93 | 1 | 2 | 3 | 0 | 0 | - | 0 | - | - |
AM140710-84 | 1 | 3 | 3 | 0 | 0 | - | 0 | - | 0 |
BZ020610-35 | 1 | 2 | 0 | 1 | 2 | 8 | 0 | 0 | 0 |
GP140710-90 | 1 | 2 | 2 | 1 | 1 | 41 | 0 | - | - |
JC070710-77 | 1 | 2 | 3 | 2 | 2 | 28 | 0 | - | 0 |
RM150610-98 | 0 | - | 2 | 0 | 0 | - | 0 | - | 0 |
MJ240510-23 | 0 | - | 3 | 0 | 0 | - | 0 | - | 1 |
EC070710-73 | 0 | - | 2 | 0 | 0 | - | 0 | - | - |
DD170510-9 | 0 | - | 3 | 0 | 0 | - | 0 | - | 0 |
FN280610-62 | 0 | - | 2 | 0 | 0 | - | 0 | - | 0 |
AM140610-50 | 0 | - | 2 | 0 | 0 | - | 0 | - | 1 |
KG170510-4 | 0 | - | 1 | 0 | 0 | - | 0 | - | 1 |
AD130710-83 | 0 | - | 2 | 0 | 0 | - | 0 | - | 0 |
AT090610-45 | 0 | - | 1 | 0 | 0 | - | 0 | - | 0 |
GN280710-107 | 0 | - | 2 | 0 | 0 | - | 0 | - | - |
MB140610-51 | 0 | - | 3 | 0 | 0 | - | 0 | - | 0 |
JM130710-82 | 0 | - | 0 | 1 | 1 | 6 | 0 | - | - |
1 Histological diagnosis: 0 = tumor-free epithelium, 1 = ESCC, 2 = dysplastic epithelium; 2 Ki-67 index: 0 ≤ 10%: negative, 1 = 10–20%: weakly positive, 2 = 20–50%: positive, 3 ≥ 50%: strongly positive; 3 p16INK4a staining pattern: 0 = focal staining, 1 = diffuse cytoplasmatic positive, 2 = diffuse nuclear positive; 4 p16INK4a staining in tumor tissue: 0 = p16INK4a negative, 1 = 20–50% positive, 2 ≥ 50% strong positive; 5 HPV in PCR: 0 = negative, 1 = positive; 6 In situ hybridization: 0 = negative; 7 HIV status: 0 = negative, 1 = positive; - not done/not evaluable.